These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34814157)

  • 21. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
    Azzouzi AR; Vincendeau S; Barret E; Cicco A; Kleinclauss F; van der Poel HG; Stief CG; Rassweiler J; Salomon G; Solsona E; Alcaraz A; Tammela TT; Rosario DJ; Gomez-Veiga F; Ahlgren G; Benzaghou F; Gaillac B; Amzal B; Debruyne FM; Fromont G; Gratzke C; Emberton M;
    Lancet Oncol; 2017 Feb; 18(2):181-191. PubMed ID: 28007457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in decisional conflict and decisional regret in patients with localised prostate cancer.
    Chien CH; Chuang CK; Liu KL; Li CL; Liu HE
    J Clin Nurs; 2014 Jul; 23(13-14):1959-69. PubMed ID: 24355000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
    Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment.
    Chelly S; Maulaz P; Bigot P; Azzouzi AR; Lebdai S
    Asian J Androl; 2020; 22(5):454-458. PubMed ID: 31939351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
    DeWitt-Foy ME; Gam K; Modlin C; Kim SP; Abouassaly R
    J Urol; 2021 Feb; 205(2):426-433. PubMed ID: 33226309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spirituality is associated with less treatment regret in men with localized prostate cancer.
    Mollica MA; Underwood W; Homish GG; Homish DL; Orom H
    Psychooncology; 2017 Nov; 26(11):1839-1845. PubMed ID: 27530290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer.
    Westhoff N; Ernst R; Kowalewski KF; Schmidt L; Worst TS; Michel MS; von Hardenberg J
    World J Urol; 2021 Apr; 39(4):1121-1129. PubMed ID: 32533247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time pressure predicts decisional regret in men with localized prostate cancer: data from a longitudinal multicenter study.
    Hilger C; Schostak M; Otto I; Kendel F
    World J Urol; 2021 Oct; 39(10):3755-3761. PubMed ID: 34021406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad.
    Madar-Balakirski N; Tempel-Brami C; Kalchenko V; Brenner O; Varon D; Scherz A; Salomon Y
    PLoS One; 2010 Apr; 5(4):e10282. PubMed ID: 20421983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity and Reliability of the Decision Regret Scale in Cancer Patients Receiving Adjuvant Chemotherapy.
    Calderon C; Ferrando PJ; Lorenzo-Seva U; Higuera O; Ramon Y Cajal T; Rogado J; Mut-Lloret M; Rodriguez-Capote A; Jara C; Jimenez-Fonseca P
    J Pain Symptom Manage; 2019 Apr; 57(4):828-834. PubMed ID: 30639730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.
    Kim K; Zhang H; La Rosa S; Jebiwott S; Desai P; Kimm S; Scherz A; O'Donoghue JA; Weber WA; Coleman JA
    Clin Cancer Res; 2017 Jul; 23(13):3343-3351. PubMed ID: 28108545
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
    Trachtenberg J; Bogaards A; Weersink RA; Haider MA; Evans A; McCluskey SA; Scherz A; Gertner MR; Yue C; Appu S; Aprikian A; Savard J; Wilson BC; Elhilali M
    J Urol; 2007 Nov; 178(5):1974-9; discussion 1979. PubMed ID: 17869307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
    Alvim R; Nagar K; Das S; Lebdai S; Wong N; Somma A; Hughes C; Thomas J; Monette S; Scherz A; Kim K; Grimm J; Coleman JA
    Eur Urol Focus; 2021 Mar; 7(2):472-478. PubMed ID: 31227464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.
    Skyring TA; Mansfield KJ; Mullan JR
    Am J Mens Health; 2021; 15(4):15579883211026812. PubMed ID: 34261353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'I'm not a chance taker': A mixed methods exploration of factors affecting prostate cancer treatment decision-making.
    Owens OL; Estrada RM; Johnson K; Cogdell M; Fried DB; Gansauer L; Kim S
    Ethn Health; 2021 Nov; 26(8):1143-1162. PubMed ID: 30987436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.
    Wilding S; Downing A; Selby P; Cross W; Wright P; Watson EK; Wagland R; Kind P; Donnelly DW; Hounsome L; Mottram R; Allen M; Kearney T; Butcher H; Gavin A; Glaser A
    Psychooncology; 2020 May; 29(5):886-893. PubMed ID: 32065691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.
    Betrouni N; Boukris S; Benzaghou F
    Lasers Med Sci; 2017 Aug; 32(6):1301-1307. PubMed ID: 28569345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of decisional conflict, decision regret and self-stigma on quality of life for breast cancer survivors: A cross-sectional, multisite study in China.
    Zhuang H; Wang L; Yu X; Chan SW; Gao Y; Li X; Gao S; Zhu J
    J Adv Nurs; 2022 Oct; 78(10):3261-3272. PubMed ID: 35396872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consultation audio-recording reduces long-term decision regret after prostate cancer treatment: A non-randomised comparative cohort study.
    Good DW; Delaney H; Laird A; Hacking B; Stewart GD; McNeill SA
    Surgeon; 2016 Dec; 14(6):308-314. PubMed ID: 25636362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
    Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
    Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.